Member Info for Bananaman2

shedjock. I had heard the same after mentioning this deal. Perhaps best to forget it and if we hear anymore it will be a bonus.

Based on £1.50 margin and 1m tests per week capacity that is £78m per annum. With a PE of 10 that's £780 MCap.

That is assuming that 1m would be sold globally and does not include anything for LFT.

A way of achieving these figures at the moment but its easy to see how the placing funds will be used to increase capacity.

Can they or will they really aim to produce 1m per week of the ELISA tests ?

Starting to see how some of the loftier MCap valuations have been estimated.

wow. Imagine selling full manufacturing capacity oer week of the ELISA tests. 1m tests per week does not go far if several countries ending up wanting it. Especially when you think India alone has 1.3bn population.

The return on sales here would be huge.

AIM is like that. Never get your hopes up.

ODX has many lines in which news will be released. I would suggest sitting back and enjoying the next few weeks for starters.

The expectation of an RNS tomorrow may be met with disappointment. But with anticipation of expected news will provide an opportunity to buy in or add more should the inevitable SP run away on release of a trigger.

This is all positive but no guarantee that anything will be RNSd tomorrow or next week. Patience will be rewarded.

Oh. OK. Sprog has referenced them.

Thats enough. No more discussion.

red-hornet. Check my post history and you will find it in there.

in fact I have an equally sized investment in a solar PV company that is targeting the diesel generator replacement market. But I would try not to discuss that on here as its perhaps of topic.

I haven't said that. In fact I have suggested how hydrogen will be used to balance renewable energy requirements. I think the key to hydrogen production will be utilising 'waste' or excess renewable energy through an electrolyser to produce green hydrogen.

Phats, great job today. Keeping your posts on topic. Hydrogen sector and AFC energy.

The world cannot rely on wind and solar alone and there is evidence that these will be heavily balanced with hydrogen energy. It just shows how AFC are right in the thick of it now.

As the world develops further there will be a change towards micro generation and less reliance on the national grids and mass power generation. AB said as much in Fridays RNS regarding AFCs being part of a customers renewable energy portfolio. I.e no reliance on one source.

Keep up the good work. Starting to see how you get you SP predictions. I am not saying I disagree but there is certainly support appearing

Testing will or should not be completed once. I think GPback, you ars saying, and I agree, that a single antibody test will not tell you enough and people will need to be tested, tracked and traced to see when antibodies are no longer present, how long they are present for and when and if you can be reinfected.

This type of testing would build a very good understanding of the virus and would result in a significant number of test. Even after a vaccine, antobody testing will be required. The test will need to be accurate and rapid as per the RTC prick test

If the article is in relation to previous testing which was unreliable the government will not continue.

As they have no found a reliable test through the RTC Iwould expect that antibody testing on mass will provide a lot of important and relevant information to help understand the virus and human protection.

Symbo1. You are getting your wires crossed. The UK government and PHE approval is not for the same test as that which is CE marked and approved for sale in India.

That is why OXD is in a very strong position having raised capital to expand facilities to scale up production. Not just for the RTC test kit but for other products related to COVID 19 testing.

Two completely separate items, amongst several other products in the portfolio.

Because AFC are 'world leaders in Alkaline Fuel Cell technology'

That is a list of followers

previous RNS was approved for sale pending submission of technical data which was suggested as not being a concern.

And that is just one piece of news we can expect over the next few weeks.

And this is possibly why Mr Prashant Maniar exercised 50000 options at 18 odd pence yesterday.

Chuggley. I would have thought sales to India would be the most imminent. Seeing as the approval RNS was recieved on the 2nd July and this was only pending technical data which was claimed to not be a problem.

Given the hindutimes article and a decision on testing to elbe rolled out at the start of August the Indian sales certainlt seem to be first mover.

But, as you have mentioned, Omega are certainly not a one trick pony and news could come from anywhere.

we should also be mindful that the AFC offering is not just a simple fuel cell run of hydrogen. AFC are offering bespoke systems that incorporate several different resources. The bespoke nature will take time to negotiate and discuss with potential customers but the fact that they can design a system which can pretty much generate its own fuel through renewable energy, use this as a store to generate on demand power at rapid rate is a major selling point. And a major selling point over others in the sector.

Now that makes more sense. Mass testing to determine protection against re-infection.

Can't do mass testing with inaccurate tests which take some time to process.

The RTC is the solution and this article states as such